Avivagen enters partnership for China approval,expands Philippines offering

摘要

Canada's Avivagen is working with the research subsidiary of Cofco Biotechnology on the regulatory process for OxC-beta Livestock in China. Cofco is a leading supplier of agri-products to the Chinese market, with over ￥17.5 billion ($2.5 billion) inannual sales in 2018. The company will work with Avivagen in China to boost approval efforts for OxC-beta feed premix.Cofco will assist Avivagen with all aspects of the approval process, including designing the protocols required for trials of OxC-beta necessary to secure authorization for use in broiler feed.